MAPK8 and acute promyelocytic leukemia: ATRA can directly target RARα to ubiquitin-proteasome degradation in APL and non-APL cells [12], while activation of c-Jun N-terminal kinase (JNK) can contribute to RAR dysfunction by phosphorylating RARα at Thr181, Ser445, and Ser461.